Arcellx (ACLX) Change in Accured Expenses (2021 - 2025)

Arcellx's (ACLX) quarterly Change in Accured Expenses came in at -$23.1 million in Q4 2025, up 16.46% year-on-year from -$19.9 million in Q4 2024, and down 536.83% quarter-over-quarter from $5.3 million in Q3 2025.

Arcellx (ACLX) Change in Accured Expenses (2021 - 2025) Analysis & Trends

Arcellx's Change in Accured Expenses history runs 5 years deep, the most recent figure standing at -$23.1 million for Q4 2025.

  • On a quarterly basis, Change in Accured Expenses rose 16.46% year-over-year to -$23.1 million in Q4 2025; TTM through Dec 2025 was -$21.4 million, a 30524.29% decrease from a year earlier, with the FY2025 full-year figure at -$21.4 million, down 30524.29% from the prior year.
  • Change in Accured Expenses fell to -$23.1 million in Q4 2025 per ACLX's latest filing, from $5.3 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $25.0 million in Q3 2024 and bottomed at -$27.7 million in Q4 2024.
  • The 5-year median for Change in Accured Expenses is $983000.0 (2021), against an average of -$427250.0.
  • Across the five-year window, Change in Accured Expenses sank 708.76% in 2023 and jumped 48228.85% in 2024, its largest moves.
  • Year by year, Change in Accured Expenses stood at $1.3 million in 2021, then plunged by 77.8% to $282000.0 in 2022, then soared by 2467.73% to $7.2 million in 2023, then plunged by 482.59% to -$27.7 million in 2024, then grew by 16.46% to -$23.1 million in 2025.
  • Per Business Quant, the three latest ACLX Change in Accured Expenses figures stand at -$23.1 million (Q4 2025), $5.3 million (Q3 2025), and -$5.8 million (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 1.13 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -16.82 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 23.10 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 107.70 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -16.74 Mn
10 Arcellx 6.48 Bn 6.48 Bn - -23.14 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -23.14 Mn
Dec 31, 2025 -23.14 Mn
Sep 30, 2025 5.30 Mn
Sep 30, 2025 5.30 Mn
Jun 30, 2025 -5.83 Mn
Jun 30, 2025 -5.83 Mn
Mar 31, 2025 2.24 Mn
Mar 31, 2025 2.24 Mn
Dec 31, 2024 -27.70 Mn
Dec 31, 2024 -27.70 Mn
Sep 30, 2024 25.03 Mn
Sep 30, 2024 25.03 Mn
Jun 30, 2024 -15.07 Mn
Jun 30, 2024 -15.07 Mn
Mar 31, 2024 17.68 Mn
Mar 31, 2024 17.68 Mn
Dec 31, 2023 7.24 Mn
Dec 31, 2023 7.24 Mn
Sep 30, 2023 -52,000.00
Sep 30, 2023 -52,000.00